Training Effects on Fuel Metabolism
TrainMeUpMN
2 other identifiers
interventional
64
1 country
1
Brief Summary
The investigators are interested in how skeletal muscle processes fat and how this may affect insulin resistance. This is an important question since insulin resistance predates and predicts type 2 diabetes. The investigators are especially interested in learning about the effects of weight and training on insulin resistance. The investigators will study people before and after supervised aerobic or yoga training to identify differences in resting fat and sugar metabolism which may lead to differences in insulin resistance. The investigators will test these differences using stable isotopes, and the use of these stable isotopes is experimental. Overweight/Obese Group: Eight visits will be required at the University of Minnesota Clinical Research Unit. Four visits will be done before training (screen and 3 pre-training visits), 1 visit during the training, and 3 post-training visits will be done. In between, the training will take about 16 weeks and will be a supervised treadmill program. Lean/Trained Group: Four visits will be required at the University of Minnesota Clinical Research Unit (screen and 3 study visits).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2014
CompletedFirst Posted
Study publicly available on registry
May 30, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJanuary 8, 2026
January 1, 2026
4.5 years
May 22, 2014
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences in insulin sensitivity between groups
Will use HOMA-IR and hyperinsulinemia-euglycemic clamp
Before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Secondary Outcomes (1)
Differences in fitness level between groups
before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Other Outcomes (1)
Differences in body composition between groups
before and after exercise program ((exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Study Arms (2)
Lean Trained
NO INTERVENTIONMetabolic control
Obese or Overweight
EXPERIMENTALRunning Program Yoga Program
Interventions
Eligibility Criteria
You may qualify if:
- All subjects
- Subjects 18 to 40 years of age.
- Subjects are capable of giving informed consent
- Overweight or obese
- Insulin resistant based on screening oral glucose tolerance testing.
- BMI 25 to 40 kg/m2 inclusive
- Stable weight for at least 3 months (± 5 lbs.)
- Sedentary status (self-report \< 30 minutes/week regular exercise).
- Lean, physically active
- physically active subjects defined as 3-5 aerobic exercise sessions/week
- matched to age and gender
- generally healthy with normal fasting glucose levels (glucose ≤100 mg/dL).
You may not qualify if:
- All subjects
- Subjects 18 to 40 years of age.
- Subjects are capable of giving informed consent
- Overweight or obese
- Insulin resistant based on screening oral glucose tolerance testing.
- BMI 25 to 40 kg/m2 inclusive
- Stable weight for at least 3 months (± 5 lbs.)
- Sedentary status (self-report \< 30 minutes/week regular exercise).
- Lean, physically active
- physically active subjects defined as 3-5 aerobic exercise sessions/week
- matched to age and gender
- generally healthy with normal fasting glucose levels (glucose ≤100 mg/dL).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Related Publications (2)
Nelson AB, Chow LS, Stagg DB, Gillingham JR, Evans MD, Pan M, Hughey CC, Myers CL, Han X, Crawford PA, Puchalska P. Acute aerobic exercise reveals that FAHFAs distinguish the metabolomes of overweight and normal-weight runners. JCI Insight. 2022 Apr 8;7(7):e158037. doi: 10.1172/jci.insight.158037.
PMID: 35192550DERIVEDBantle AE, Bosch TA, Dengel DR, Wang Q, Mashek DG, Chow LS. DXA-Determined Regional Adiposity Relates to Insulin Resistance in a Young Adult Population with Overweight andObesity. J Clin Densitom. 2019 Apr-Jun;22(2):287-292. doi: 10.1016/j.jocd.2018.06.001. Epub 2018 Jun 7.
PMID: 30064815DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa S. Chow, MD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 22, 2014
First Posted
May 30, 2014
Study Start
July 1, 2014
Primary Completion
December 30, 2018
Study Completion (Estimated)
December 31, 2026
Last Updated
January 8, 2026
Record last verified: 2026-01